U.S. markets closed
  • S&P 500

    -23.89 (-0.54%)
  • Dow 30

    -149.06 (-0.42%)
  • Nasdaq

    -105.59 (-0.71%)
  • Russell 2000

    -13.78 (-0.62%)
  • Crude Oil

    +0.09 (+0.12%)
  • Gold

    -18.70 (-1.02%)
  • Silver

    -0.24 (-0.92%)

    -0.0020 (-0.17%)
  • 10-Yr Bond

    -0.0300 (-2.36%)

    -0.0048 (-0.34%)

    +0.2110 (+0.19%)

    +645.56 (+1.62%)
  • CMC Crypto 200

    +5.13 (+0.54%)
  • FTSE 100

    -46.12 (-0.65%)
  • Nikkei 225

    -498.83 (-1.80%)

Anthem (ANTM), Epic Collaborate for Better Consumer Experience

·3 min read

Anthem, Inc. ANTM ties up with Epic for safe and seamless, bi-directional health information exchange between healthcare providers and the company’s affiliated health plans. Notably, Epic is a leading health information company.

This move is made at an opportune moment as better communication can lead to enhanced data-driven insights for improved health outcomes. It will eradicate barriers that can hamper an individual’s care.

This is not the first time that Anthem adopted the digital-first approach. With access to insights and proper data, patients can now gain from an enriched medical care experience. The new deal is expected to help 14.7 million consumers who come under Anthem’s affiliated health plans, seeking care from clinicians using Epic’s software.

The platform consists of various kinds of data, such as clinical information, admission and discharge information, and transfer data, mainly bridging the clinical gaps. Notably, Epic’s Payer Platform will be integrated with Anthem’s Health OS.

Anthem will now be able to get health information provided by clinicians and analyse the same for data-driven insights.

Some benefits of this include streamlining administrative processes, boosting care management with near real-time access to health data, et al.

Healthcare system and providers who use Epic can now gain traction from the Payer Platform. Anthem will also leverage data received from sources like health information exchanges, labs companies and other partners.

Digital solutions will drive growth for the company. On its last earnings call, management had said that close to 10 million individuals are engaged in Anthem’s digital channels with access to a huge range of virtual care specialties.

Anthem’s tie-ups with K and Blackstone also helped it accelerate the use of digital AI for a better consumer experience. Its digital solution suite is evolving with time for delivering exceptional experiences to consumers.
These initiatives poise the leading health insurer well for long-term growth.

Zacks Rank and Performance of Other Companies

Shares of this presently Zacks Rank #3 (Hold) company have gained 41.2% in the past year, outperforming its industry’s growth of 35.7%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Other companies in the same space, such as The Joint Corp. JYNT, Centene Corporation CNC and Select Medical Holdings Corporation SEM have also rallied 291.9%, 8.5% and 138.6%, respectively, in the same time frame.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Centene Corporation (CNC) : Free Stock Analysis Report

Select Medical Holdings Corporation (SEM) : Free Stock Analysis Report

Anthem, Inc. (ANTM) : Free Stock Analysis Report

The Joint Corp. (JYNT) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research